Leading Developer of Multiplex Molecular Technologies and Multiplex Clinical Molecular Diagnostics | SML Genetree
SML
Genetree is a leading
developer of multiplex molecular technologies and multiplex clinical molecular diagnostics based in South Korea. SML Genetree is
recognized as a premier partner in developing technology and on-time delivery,
providing both basic research in molecular biology and applied research in
molecular diagnosis. SML Genetree has succeeded in commercializing the Ezplex
HPV 100 NGS Kit, gaining global recognition. In 2020, SML Genetree developed
Ezplex COVID-19 RT PCR test kits and founded SML Genetree Sciences to expand
into the US market. SML Genetree was one of the first companies with a COVID-19
test to obtain emergency use approval from the South Korean Ministry of Food
and Drug Safety (MFDS).
✔COVID-19
✔Respiratory pathogen
diagnostic kit (up to 19 respiratory viruses and 6 types of pneumonia-causing
bacteria, including SARS-CoV-2 (COVID-19)/Flu A/Flu B/RSV diagnostic kit)
✔Sexually Transmitted
Infections diagnostic kits
✔Tuberculosis &
Non-TB diagnostic kit
✔H. pylori and resistance
diagnostic kit
✔HPV genotyping
diagnostic kits (NGS)
✔HLA diagnostic kits for
organ transplant (NGS)
✔Other viral infections:
HBV, HCV, HIV, SFTS
Reliable Solution for the COVID- 19 Outbreak
The test can be quickly and
accurately completed through PCR with extracted RNA, and the results can be
conveniently viewed using Genetree Viewer assay software.
Click here to contact SML Genetree.
Comments
Post a Comment